Tag: CAPA

Vendor Lifecycle Management: From Onboarding to Exit and Knowledge Transfer

Posted on By digi

Vendor Lifecycle Management: From Onboarding to Exit and Knowledge Transfer Vendor Lifecycle Management: From Onboarding to Exit and Knowledge Transfer In the complex landscape of clinical trials, effective vendor lifecycle management plays a crucial role in ensuring trial integrity, compliance, and success. This article provides a comprehensive step-by-step tutorial aimed at clinical operations, regulatory affairs,…

Read More “Vendor Lifecycle Management: From Onboarding to Exit and Knowledge Transfer” »

Vendor Quality Oversight & Audits

Governance Committees for High-Risk and Cross-Functional CAPAs

Posted on By digi

Governance Committees for High-Risk and Cross-Functional CAPAs In clinical research, effective governance is fundamental for maintaining compliance with Good Clinical Practice (GCP) guidelines, particularly when addressing Corrective and Preventive Actions (CAPAs). High-risk and cross-functional CAPAs, which often arise from complex regulatory findings or clinical trial discrepancies, require a structured approach to governance to ensure proper…

Read More “Governance Committees for High-Risk and Cross-Functional CAPAs” »

CAPA Integration with GCP Findings

Preparing CAPA Narratives and Evidence Packages for Re-Inspections

Posted on By digi

Preparing CAPA Narratives and Evidence Packages for Re-Inspections Corrective and Preventive Actions (CAPA) are integral to clinical trial management. They provide a systematic approach to addressing findings from regulatory inspections or audits in accordance with Good Clinical Practice (GCP). This in-depth tutorial will guide clinical operations, regulatory affairs, and medical affairs professionals through the process…

Read More “Preparing CAPA Narratives and Evidence Packages for Re-Inspections” »

CAPA Integration with GCP Findings

Managing Audit Findings, CAPAs and Follow-Up With Strategic Vendors

Posted on By digi

Managing Audit Findings, CAPAs and Follow-Up With Strategic Vendors Managing Audit Findings, CAPAs and Follow-Up With Strategic Vendors Introduction to Vendor Quality Oversight in Clinical Trials In the landscape of clinical trials, vendor management plays a pivotal role in ensuring compliance with Good Clinical Practice (GCP) and regulatory standards set forth by authorities such as…

Read More “Managing Audit Findings, CAPAs and Follow-Up With Strategic Vendors” »

Vendor Quality Oversight & Audits

Aligning Vendor QMS Expectations With Sponsor and CRO Requirements

Posted on By digi

Aligning Vendor QMS Expectations With Sponsor and CRO Requirements Aligning Vendor QMS Expectations With Sponsor and CRO Requirements In the evolving landscape of clinical trials, ensuring quality management system (QMS) compliance between sponsors and contract research organizations (CROs) is crucial for successful patient enrollment in clinical trials. This step-by-step guide serves as a comprehensive tutorial…

Read More “Aligning Vendor QMS Expectations With Sponsor and CRO Requirements” »

Vendor Quality Oversight & Audits

Case Studies: CAPAs That Satisfied Regulators vs CAPAs That Failed

Posted on By digi

Case Studies: CAPAs That Satisfied Regulators vs CAPAs That Failed Case Studies: CAPAs That Satisfied Regulators vs CAPAs That Failed Corrective and Preventive Actions (CAPAs) play a crucial role in ensuring compliance within clinical trial frameworks. They are essential not only for meeting regulatory expectations but also for improving overall clinical research quality. This article…

Read More “Case Studies: CAPAs That Satisfied Regulators vs CAPAs That Failed” »

CAPA Integration with GCP Findings

Using CAPA Metrics to Drive a Culture of Continuous GCP Improvement

Posted on By digi

Using CAPA Metrics to Drive a Culture of Continuous GCP Improvement Using CAPA Metrics to Drive a Culture of Continuous GCP Improvement In the field of clinical trials, adherence to Good Clinical Practice (GCP) is paramount to ensuring the integrity of data and the safety of participants. The integration of Corrective and Preventive Action (CAPA)…

Read More “Using CAPA Metrics to Drive a Culture of Continuous GCP Improvement” »

CAPA Integration with GCP Findings

Digital CAPA Tools and Workflows for Global Clinical Organizations

Posted on By digi

Digital CAPA Tools and Workflows for Global Clinical Organizations Digital CAPA Tools and Workflows for Global Clinical Organizations The integration of Corrective and Preventive Actions (CAPA) into clinical trial processes is critical for maintaining Good Clinical Practice (GCP) compliance. It ensures that clinical research organizations can address non-compliance and improve study quality effectively. This tutorial…

Read More “Digital CAPA Tools and Workflows for Global Clinical Organizations” »

CAPA Integration with GCP Findings

Planning and Conducting Vendor Audits for Labs, eCOA, DCT and More

Posted on By digi

Planning and Conducting Vendor Audits for Labs, eCOA, DCT and More In the field of clinical research and trials, maintaining regulatory compliance and ensuring quality management is critical. Vendor audits become essential when dealing with external partners such as laboratories providing testing services, suppliers for electronic Clinical Outcome Assessments (eCOA), and decentralized clinical trial (DCT)…

Read More “Planning and Conducting Vendor Audits for Labs, eCOA, DCT and More” »

Vendor Quality Oversight & Audits

Audit Programs Driven by Risk, Spend and Criticality of Vendor Services

Posted on By digi

Audit Programs Driven by Risk, Spend and Criticality of Vendor Services Audit Programs Driven by Risk, Spend and Criticality of Vendor Services In today’s complex landscape of clinical research and trials, the importance of robust vendor management cannot be overstated. The integration of vendors in clinical trials often brings about challenges that need systematic oversight….

Read More “Audit Programs Driven by Risk, Spend and Criticality of Vendor Services” »

Vendor Quality Oversight & Audits